bivalirudin
- Strength
- 250 mg/1
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Anti-coagulant; Direct Thrombin Inhibit…
Sandoz Inc
Not stocked by us — reference only
Listed by Meitheal Pharmaceuticals Inc.
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Anti-coagulant; Direct Thrombin Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 71288-427 |
| FDA application | ANDA091602 |
| RxNorm concept | 308769 |
| Package sizes listed | 1 |
| Marketed since | July 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Sandoz Inc
Not stocked by us — reference only
Slate Run Pharmaceuticals, LLC
Not stocked by us — reference only
Eugia US LLC
Not stocked by us — reference only
Mylan Institutional LLC
Not stocked by us — reference only
MAIA Pharmaceuticals, Inc.
Not stocked by us — reference only
Par Health USA, LLC
Not stocked by us — reference only
Civica, Inc.
Not stocked by us — reference only
Avenacy, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.